Clinical Characteristics, Prognostic Factors and Outcomes of Paediatric Patients with Haemophagocytic Lymphohistiocytosis
DOI:
https://doi.org/10.51985/JBUMDC2024320Keywords:
HLH, Liver enzymes; Prognosis; Clinical characteristicsAbstract
Objective: Haemophagocytic lymphohistiocytosis (HLH) is a multi-system autoimmune disorder. The objective of this study was to find out the clinical characteristics and prognosis of paediatric patients with Haemophagocytic Lymphohistiocytosis. Study Design and setting: Cross sectional study conducted at Pak Emirates Military Hospital, Rawalpindi from July 2021 to June 2023.
Methodology: Children with diagnosis of HLH were assessed by including patients who were aged = 13 years during hospitalization. All the patients who had not been diagnosed by using the HLH-2004 criteria were disqualified. Relevant findings were noted by evaluating records pertinent to physical examination, radiology and laboratory markers. Prognosis was assessed by determining the underlying clinical aetiology and whether patient-related factors modulated the overall life expectancy.
Results: A total of 32 patient records were evaluated. Mean age at diagnosis was 44.3 ± 39.1 months (Range: 1-132 months) with majority being males [n=23 (71.9%)]. The common clinical characteristics included fever [n=29 (90.6%)], lymphadenopathy [n=27 (84.4%)], splenomegaly [n=23 (71.9%)] and hepatomegaly [n=23 (71.9%)]. Serum ferritin, bilirubin, ALT, AST, and LDH were also raised. All patients were followed for a mean period of 12 months and 18 (56.3%) children failed to survive. Negative prognostic indicators included severe anaemia (p=0.001), neutropenia (p=0.007), thrombocytopenia (p=0.033), and hyperferritinemia (p<0.001). Elevation of liver enzymes (ALT: p<0.001; AST: p=0.031), serum bilirubin (p=0.037), and LDH (p<0.001) also indicated worse disease prognosis.
Conclusion: HLH in childhood is a potentially life-threatening disease and carries a significant association with deranged liver function
References
Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and
therapy. Best Pract Res Clin Rheumatol. 2020;34(4):101515.
https://pubmed.ncbi.nlm.nih.gov/32387063/
Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020 ;135(16):1332–43. https://ashpublications.org/blood/article/135/16/1332/452577/Pediatrichemophagocytic-lymphohistiocytosis
Chen X, Wang F, Zhang Y, Teng W, Wang M, Nie D, et al.
Genetic variant spectrum in 265 Chinese patients with hemophagocytic lymphohistiocytosis: Molecular analyses of
PRF1, UNC13D, STX11, STXBP2, SH2D1A, and XIAP.
Clin Genet. 2018;94(2):200–12. https://pubmed. ncbi.nlm.nih.gov/29665027/
Chesshyre E, Ramanan AV, Roderick MR. Hemophagocytic
lymphohistiocytosis and infections: An update. Pediatr Infec
tDis J. 2019 38(3):e546. https://pubmed.ncbi.nlm. nih.gov/
/
Li J, Gao C, Zhu X, Yang D, Mao W, Yao H, et al. Hemophagocytic lymphohistiocytosis secondary to virus infection and
followed by lupus nephritis recurrence in a renal transplantation
pediatric recipient: a case report. BMC Nephrol. 2023;24(1).
http://dx.doi.org/10.1186/s12882-023-03249-4
Nandhakumar D, Loganatha A, Sivasankaran M, Sivabalan
S, Munirathnam D. Hemophagocytic lymphohistiocytosis in
children. Indian J Pediatr. 2020 ;87(7):526–31. https://pubmed.ncbi.nlm.nih.gov/32056194/
Qiu K-Y, Guo S-Y, Zeng Y-H, Liao X-Y, Lin S-F, Fang J-P,
et al. Analysis of clinical characteristics and prognostic factors
associated with EBV-associated HLH in children. Hematology.
;27(1):874–80. https://pubmed.ncbi.nlm. nih.gov/
/
Kwak A, Jung N, Shim YJ, Kim HS, Lim HJ, Lee JM, et al.
A retrospective analysis of etiology and outcomes of hemophagocytic lymphohistiocytosis in children and adults. Yeungnam
Univ J Med. 2021 ;38(3):208–18. https://pubmed.ncbi.nlm.
nih.gov/33242384/
Zhou Y-H, Han X-R, Xia F-Q, Poonit N-D, Liu L. Clinical
features and prognostic factors of early outcome in pediatric
hemophagocytic lymphohistiocytosis: A retrospective analysis
of 227 cases. J Pediatr Hematol Oncol. 2022 ;44(1):e217–22.
https://pubmed.ncbi.nlm.nih.gov/34986134/
Otrock ZK, Eby CS. Clinical characteristics, prognostic
factors, and outcomes of adult patients with hemophagocytic
lymphohistiocytosis. Am J Hematol. 2015;90(3):220–4. https://pubmed.ncbi.nlm.nih.gov/25469675/
Benevenuta C, Mussinatto I, Orsi C, Timeus F. Secondary
hemophagocytic lymphohistiocytosis in children (Review).
Exp Ther Med. 2023;26(3). http://dx.doi.org/1 0.3892/etm
.2023.1212
Kim YR, Kim D-Y. Current status of the diagnosis and
treatment of hemophagocytic lymphohistiocytosis in adults.
Blood Res. 2021;56(S1):S17–25. https://pubmed. ncbi.nlm.nih.gov/33935031/
Zhang Z, Wang J, Ji B, von Bahr Greenwood T, Zhang Y,
Wang Y, et al. Clinical presentation of hemophagocytic
lymphohistiocytosis in adults is less typical than in children.
Clinics (Sao Paulo). 2016;71(4):205–9. http://dx.doi.org
/10.6061/clinics/2016(04)05
Abdullatif H, Mohsen N, El-Sayed R, El-Mougy F, El-Karaksy
H. Haemophagocytic lymphohistiocytosis presenting as neonatal liver failure: A case series. Arab J Gastroenterol,
;17(2):105–9. https://pubmed.ncbi.nlm.nih.gov/27397412/
Amir AZ, Ling SC, Naqvi A, Weitzman S, Fecteau A, Grant
D, et al. Liver transplantation for children with acute liver
failure associated with secondary hemophagocytic lymphohistiocytosis. Liver Transpl. 2016 ;22(9):1245–53. https://pubmed.ncbi.nlm.nih.gov/27216884/
Koh K-N, Im HJ, Chung N-G, Cho B, Kang HJ, Shin HY, et
al. Clinical features, genetics, and outcome of pediatric patients
with hemophagocytic lymphohistiocytosis in Korea: report
of a nationwide survey from Korea Histiocytosis Working
Party. Eur J Haematol. 2015;94(1):51–9. https://pubmed
.ncbi.nlm.nih.gov/24935083/
Huang Z, Jia Y, Zuo Y, Wu J, Lu A, Zhang L. Malignancyassociated hemophagocytic lymphohistiocytosis in children:
a 10-year experience of a single pediatric hematology center.
Hematology. 2020;25(1):389–99. https://pubmed.ncbi
.nlm.nih.gov/33161882/
Tan CJ-W, Ng ZQ, Bhattacharyya R, Sultana R, Lee JH.
Treatment and mortality of hemophagocytic lymphohistiocytosis in critically ill children: A systematic review and metaanalysis. Pediatr Blood Cancer. 2023;70(3). https://pubmed.
ncbi.nlm.nih.gov/36579732/
Xu X-J, Wang H-S, Ju X-L, Xiao P-F, Xiao Y, Xue H-M, et
al. Clinical presentation and outcome of pediatric patients
with hemophagocytic lymphohistiocytosis in China: A retrospective multicenter study: XU ET AL. Pediatr Blood Cancer.
;64(4):e26264. https://pubmed.ncbi. nlm.nih.gov/
/
Ishii E. Hemophagocytic Lymphohistiocytosis in Children:
Pathogenesis and Treatment. Front Pediatr. 2016 https://pubmed.ncbi.nlm.nih.gov/27242976
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Sehar Aslam, Nadeem Sadiq, Tariq Nadeem, Awais Arshed, Imrana Atta, Kiran Minhas
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
